EndoBarrier

DEVICE7 trials

Sponsors

Morphic Medical Inc., Sheba Medical Center, Maastricht University Medical Center, Medical University of Graz, Dr Bob Ryder

Conditions

DiabetesObesityObstructive Sleep ApnoeaType 2 DiabetesType II Diabetes

Phase 4

Endobarrier Treatment in Obese Subjects With T2DM

Sheba Medical CenterObesity, Type 2 Diabetes

Start: 2012-12-31End: 2018-01-31Target: 45Updated: 2014-07-01

Unknown Phase

Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity

CompletedNCT00985114

Morphic Medical Inc.Type II Diabetes

Start: 2009-10-31End: 2013-01-31Updated: 2016-10-03

Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese

TerminatedNCT01728116

Morphic Medical Inc.Obesity, Type 2 Diabetes

Start: 2012-12-31End: 2016-02-29Updated: 2017-02-01

An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier® Gastrointestinal Liner System

WithdrawnNCT02293720

Morphic Medical Inc.Type 2 Diabetes

Start: 2015-04-30End: 2016-07-31Updated: 2016-09-14

The EndoBarrier Device: A 3-year Follow up Study

CompletedNCT02566330

Maastricht University Medical CenterDiabetes, Obesity

Start: 2015-10-31End: 2016-02-29Updated: 2016-07-11

EndoBarrier in Obese Subjects With Type 2 Diabetes Mellitus

CompletedNCT02769728

Medical University of GrazObesity, Type 2 Diabetes

Start: 2016-02-29End: 2019-01-31Updated: 2024-04-08

EndoBarrier in Obstructive Sleep Apnoea Study

CompletedNCT06376305

Dr Bob RyderObesity, Obstructive Sleep Apnoea, Type 2 Diabetes

Start: 2016-03-31End: 2019-12-31Updated: 2024-04-19

Related Papers

Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial.

PubMed2022-03-0120 citations

Efficacy and Safety of the Duodeno-Jejunal Bypass Liner in Patients With Metabolic Syndrome

Annals of Surgery2020-09-0318 citations

Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial

Diabetes Therapy2018-12-116 citations

Design of the Weight-loss Endoscopy Trial (WET): a multi-center, randomized, controlled trial comparing weight loss in endoscopically implanted duodenal-jejunal bypass liners vs. intragastric balloons vs. a sham procedure.

2018-07-186 citations

Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease.

2013-08-0337 citations